Consultation: Increasing Access to Nonprescription Drugs

A consultation involves a targeted inquiry aimed at gathering expert insights to inform policy decisions. Typically lasting for several months, these consultations invite contributions from academics to provide evidence-based recommendations. The findings may support policy development, inform debates, or guide decision-making processes.

Description

The Food and Drug Administration (FDA, the Agency, or we) is announcing a public meeting entitled “Increasing Access to Nonprescription Drugs.” The purpose of the public meeting is to discuss perspectives from interested parties on increasing access to nonprescription drugs. We are also requ&hel